- Home
- /
- News
- /
- Target Identification/ Validation
- /
- January 2013
Target Identification/ Validation News for January 2013
Cancer Research UK and its commercial arm Cancer Research Technology (CRT) are launching a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death. The ‘master-switch’ experimental drug, owned by Astex Pharmaceuticals, could potentially treat a range of cancer types.
21 January, 2013